Health outcome measures in atopic dermatitis: A systematic review of trends in disease severity and quality-of-life instruments 1985-2010

Balvinder Rehal, April Armstrong

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Background: A number of disease-severity and quality-of-life (QoL) instruments have emerged in atopic dermatitis (AD) in the last decade. Objectives: To identify trends in outcomes instruments used in AD clinical trials and to provide a useful summary of the dimensions and validation studies for the most commonly used measures. Method: All randomized control trials (RCTs) from 1985 to 2010 in the treatment of AD were examined. Results: Among the 791 RCTs reviewed, we identified 20 disease-severity and 14 QoL instruments. Of these outcomes instruments, few have been validated. SCORAD, EASI, IGA and SASSAD were the most commonly used disease-severity instruments and CDLQI, DFI, DLQI and IDQOL were the most frequently used QoL measures. Limitations: The small number of RCTs using QoL scales makes identifying trends for QoL instruments difficult. Conclusion: Overall, there is an increase in the use of disease-severity and QoL instruments in AD clinical trials.

Original languageEnglish (US)
Article numbere17520
JournalPLoS One
Volume6
Issue number4
DOIs
StatePublished - 2011

Fingerprint

atopic dermatitis
systematic review
Atopic Dermatitis
quality of life
disease severity
Quality of Life
Outcome Assessment (Health Care)
Health
clinical trials
Clinical Trials
Validation Studies

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Health outcome measures in atopic dermatitis : A systematic review of trends in disease severity and quality-of-life instruments 1985-2010. / Rehal, Balvinder; Armstrong, April.

In: PLoS One, Vol. 6, No. 4, e17520, 2011.

Research output: Contribution to journalArticle

@article{a46e25d58d134e6fa02bb434ba01b893,
title = "Health outcome measures in atopic dermatitis: A systematic review of trends in disease severity and quality-of-life instruments 1985-2010",
abstract = "Background: A number of disease-severity and quality-of-life (QoL) instruments have emerged in atopic dermatitis (AD) in the last decade. Objectives: To identify trends in outcomes instruments used in AD clinical trials and to provide a useful summary of the dimensions and validation studies for the most commonly used measures. Method: All randomized control trials (RCTs) from 1985 to 2010 in the treatment of AD were examined. Results: Among the 791 RCTs reviewed, we identified 20 disease-severity and 14 QoL instruments. Of these outcomes instruments, few have been validated. SCORAD, EASI, IGA and SASSAD were the most commonly used disease-severity instruments and CDLQI, DFI, DLQI and IDQOL were the most frequently used QoL measures. Limitations: The small number of RCTs using QoL scales makes identifying trends for QoL instruments difficult. Conclusion: Overall, there is an increase in the use of disease-severity and QoL instruments in AD clinical trials.",
author = "Balvinder Rehal and April Armstrong",
year = "2011",
doi = "10.1371/journal.pone.0017520",
language = "English (US)",
volume = "6",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Health outcome measures in atopic dermatitis

T2 - A systematic review of trends in disease severity and quality-of-life instruments 1985-2010

AU - Rehal, Balvinder

AU - Armstrong, April

PY - 2011

Y1 - 2011

N2 - Background: A number of disease-severity and quality-of-life (QoL) instruments have emerged in atopic dermatitis (AD) in the last decade. Objectives: To identify trends in outcomes instruments used in AD clinical trials and to provide a useful summary of the dimensions and validation studies for the most commonly used measures. Method: All randomized control trials (RCTs) from 1985 to 2010 in the treatment of AD were examined. Results: Among the 791 RCTs reviewed, we identified 20 disease-severity and 14 QoL instruments. Of these outcomes instruments, few have been validated. SCORAD, EASI, IGA and SASSAD were the most commonly used disease-severity instruments and CDLQI, DFI, DLQI and IDQOL were the most frequently used QoL measures. Limitations: The small number of RCTs using QoL scales makes identifying trends for QoL instruments difficult. Conclusion: Overall, there is an increase in the use of disease-severity and QoL instruments in AD clinical trials.

AB - Background: A number of disease-severity and quality-of-life (QoL) instruments have emerged in atopic dermatitis (AD) in the last decade. Objectives: To identify trends in outcomes instruments used in AD clinical trials and to provide a useful summary of the dimensions and validation studies for the most commonly used measures. Method: All randomized control trials (RCTs) from 1985 to 2010 in the treatment of AD were examined. Results: Among the 791 RCTs reviewed, we identified 20 disease-severity and 14 QoL instruments. Of these outcomes instruments, few have been validated. SCORAD, EASI, IGA and SASSAD were the most commonly used disease-severity instruments and CDLQI, DFI, DLQI and IDQOL were the most frequently used QoL measures. Limitations: The small number of RCTs using QoL scales makes identifying trends for QoL instruments difficult. Conclusion: Overall, there is an increase in the use of disease-severity and QoL instruments in AD clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=79954574126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954574126&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0017520

DO - 10.1371/journal.pone.0017520

M3 - Article

C2 - 21533286

AN - SCOPUS:79954574126

VL - 6

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e17520

ER -